Audit 60591

FY End
2022-06-30
Total Expended
$9.25M
Findings
0
Programs
1
Year: 2022 Accepted: 2022-12-07
Auditor: McKonly & Asbury

Organization Exclusion Status:

Checking exclusion status...

Findings

No findings recorded

Programs

ALN Program Spent Major Findings
93.103 Food and Drug Administration_research $100,707 Yes 0

Contacts

Name Title Type
UFLXUY7KGRK1 Krystal Reed Auditee
7177572888 Gary Dubas Auditor
No contacts on file

Notes to SEFA

Title: BASIS OF PRESENTATION Accounting Policies: Expenditures reported on the Schedule are reported on the cash basis of accounting, and, accordingly, represent the total cash expended for the program. The Schedule does not include transactions that might be included using the accrual basis of accounting as contemplated by generally accepted accounting principles. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. De Minimis Rate Used: N Rate Explanation: The auditee did not use the de minimis cost rate. The accompanying schedule of expenditures of federal awards (the Schedule) includes the federal award activity of Association of Food and Drug Officials under programs of the federal government for the year ended June 30, 2022. The information in this Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Because the Schedule presents only a selected portion of the operations of Association of Food and Drug Officials, it is not intended to and does not present the financial position, changes in net assets, or cash flows of Association of Food and Drug Officials